Biorelate
PrivateLast Round
Series A
Nov 29, 2022
Total Funding Raised
$9.12M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Biorelate is a biotechnology company that provides an AI-driven platform called Galactic AI™ for biomedical data curation to accelerate drug discovery and research.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, NLP & Conversational AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biorelate Comparables
Compare Biorelate with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Causaly | 88% | |
| ONTOFORCE | 83% | |
| Data4Cure, Inc. | 81% |
Biorelate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 29, 2022 | ||||
| Grant | Feb 18, 2019 | ||||
| Seed | Sep 18, 2018 |
Biorelate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Triple Point Ventures | Series A |
| Innovate UK | Grant |
| YFM Equity Partners | Series A |
| Catapult Ventures | Seed |
| Maven Capital Partners | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 264% MoM, reaching 4.6K.
- Nov 29, 2022
$8M round led by Maven Capital Partners and YFM Equity Partners.
Biorelate Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biorelate's valuation, stock price, and market status.
Is Biorelate a public or private company?
Biorelate is a private company.
What is the current stock price of Biorelate?
Biorelate is a private company, so its shares have no public market price. Caplight tracks Biorelate's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biorelate worth (valuation)?
Valuation information for Biorelate is not publicly available.
Can I buy Biorelate stock?
Biorelate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biorelate's last funding round?
Biorelate's most recent funding round was Series A on November 29, 2022.
Who are the main investors in Biorelate?
Key investors in Biorelate include YFM Equity Partners.
Will Biorelate IPO soon?
No public IPO plans have been announced for Biorelate.
How can I track Biorelate secondary market activity?
Caplight tracks bids, offers, and trades in Biorelate's shares on secondary markets.